Island Pharmaceuticals Statistics

Total Valuation

ASX:ILA has a market cap or net worth of AUD 36.59 million. The enterprise value is 32.60 million.

Market Cap	36.59M
Enterprise Value	32.60M

Important Dates

The next estimated earnings date is Monday, August 25, 2025.

Earnings Date	Aug 25, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:ILA has 236.09 million shares outstanding. The number of shares has increased by 49.16% in one year.

Current Share Class	236.09M
Shares Outstanding	236.09M
Shares Change (YoY)	+49.16%
Shares Change (QoQ)	+44.29%
Owned by Insiders (%)	44.12%
Owned by Institutions (%)	4.70%
Float	108.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	91.63
PB Ratio	9.41
P/TBV Ratio	9.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.05
EV / Sales	81.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.27

Current Ratio	10.27
Quick Ratio	9.85
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-52.73

Financial Efficiency

Return on equity (ROE) is -143.22% and return on invested capital (ROIC) is -79.39%.

Return on Equity (ROE)	-143.22%
Return on Assets (ROA)	-65.80%
Return on Invested Capital (ROIC)	-79.39%
Return on Capital Employed (ROCE)	-82.21%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +101.30% in the last 52 weeks. The beta is 0.09, so ASX:ILA's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	+101.30%
50-Day Moving Average	0.18
200-Day Moving Average	0.16
Relative Strength Index (RSI)	46.66
Average Volume (20 Days)	689,868

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ILA had revenue of AUD 399,366 and -3.24 million in losses. Loss per share was -0.03.

Revenue	399,366
Gross Profit	-1.30M
Operating Income	-3.20M
Pretax Income	-3.24M
Net Income	-3.24M
EBITDA	n/a
EBIT	-3.20M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 3.99 million in cash and n/a in debt, giving a net cash position of 3.99 million or 0.02 per share.

Cash & Cash Equivalents	3.99M
Total Debt	n/a
Net Cash	3.99M
Net Cash Per Share	0.02
Equity (Book Value)	3.89M
Book Value Per Share	0.02
Working Capital	3.89M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.89M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-800.87%
Pretax Margin	-811.95%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:ILA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.16%
Shareholder Yield	n/a
Earnings Yield	-8.86%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:ILA has an Altman Z-Score of 9.88 and a Piotroski F-Score of 2.

Altman Z-Score	9.88
Piotroski F-Score	2